María
Díez Campelo
Profesora Asociada CC. Salud
Yale School of Medicine
New Haven, Estados UnidosPublicaciones en colaboración con investigadores/as de Yale School of Medicine (6)
2024
2023
-
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes
Blood
-
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study
Annals of Hematology, Vol. 102, Núm. 2, pp. 311-321
2022
2020
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151